Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Queen RX vs Vital Harmony Rx

Queen RX
Graded #192

Higher grade

vs+14.599999999999994
Vital Harmony Rx
Graded #484

Lower grade

The verdict

Queen RX takes it — 66.3/100 to 51.7/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +32
77
45
Dose & formulationQueen RX +17
57
40
Clinical oversightQueen RX +4
69
65
Labs & monitoringQueen RX +3
53
50
FulfillmentQueen RX +12
75
63
Contract termsQueen RX +6
61
55
Queen RX · left barVital Harmony Rx · right bar

The numbers

MetricQueen RXVital Harmony Rx
WeighScore66.3/10051.7/100
GradeCC
Scorecard rank#192#484
Semaglutide$100/mo (quarterly plan, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
Coverage45 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV
Vital Harmony Rx

Graded #484 · C

Strengths

  • Verified LegitScript certification (ID 49230211) — a trust signal many compounded-GLP-1 DTC brands lack
  • Explicit compounded-medication + 'not a pharmacy/manufacturer' disclosure on-site
  • Both a semaglutide (GLP-1+B12) and a tirzepatide (GLP-1/GIP+B12) option
  • Operates on a named physician network (Beluga Health)

Where it loses points

  • NO pricing published anywhere on the site — a major gap for a cost-comparison directory; buyers cannot evaluate value without contacting the company
  • No specific state list (only 'entire country' claimed)
  • No named compounding pharmacy partner
  • No named medical director / PIC, no legal entity or governing law disclosed
  • Molecule strengths/dose tiers not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard